These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21161247)

  • 21. Selective changes in cytosolic β-adrenergic cAMP signals and L-type Calcium Channel regulation by Phosphodiesterases during cardiac hypertrophy.
    Abi-Gerges A; Castro L; Leroy J; Domergue V; Fischmeister R; Vandecasteele G
    J Mol Cell Cardiol; 2021 Jan; 150():109-121. PubMed ID: 33184031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias.
    Molina CE; Leroy J; Richter W; Xie M; Scheitrum C; Lee IO; Maack C; Rucker-Martin C; Donzeau-Gouge P; Verde I; Llach A; Hove-Madsen L; Conti M; Vandecasteele G; Fischmeister R
    J Am Coll Cardiol; 2012 Jun; 59(24):2182-90. PubMed ID: 22676938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease.
    Osadchii OE
    Cardiovasc Drugs Ther; 2007 Jun; 21(3):171-94. PubMed ID: 17373584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling.
    Houslay MD; Baillie GS; Maurice DH
    Circ Res; 2007 Apr; 100(7):950-66. PubMed ID: 17431197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
    Collins DM; Murdoch H; Dunlop AJ; Charych E; Baillie GS; Wang Q; Herberg FW; Brandon N; Prinz A; Houslay MD
    Cell Signal; 2008 Dec; 20(12):2356-69. PubMed ID: 18845247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK.
    Li X; Vadrevu S; Dunlop A; Day J; Advant N; Troeger J; Klussmann E; Jaffrey E; Hay RT; Adams DR; Houslay MD; Baillie GS
    Biochem J; 2010 Apr; 428(1):55-65. PubMed ID: 20196770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart.
    Shakur Y; Fong M; Hensley J; Cone J; Movsesian MA; Kambayashi J; Yoshitake M; Liu Y
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):417-27. PubMed ID: 12652111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes.
    Sin YY; Edwards HV; Li X; Day JP; Christian F; Dunlop AJ; Adams DR; Zaccolo M; Houslay MD; Baillie GS
    J Mol Cell Cardiol; 2011 May; 50(5):872-83. PubMed ID: 21334344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct phosphodiesterase-4D variants integrate into protein kinase A-based signaling complexes in cardiac and vascular myocytes.
    Raymond DR; Carter RL; Ward CA; Maurice DH
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H263-71. PubMed ID: 19060129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis.
    Omar B; Zmuda-Trzebiatowska E; Manganiello V; Göransson O; Degerman E
    Cell Signal; 2009 May; 21(5):760-6. PubMed ID: 19167487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal regulation of calcium dependent and calcium independent cyclic AMP hydrolysis by protein phosphorylation.
    Ang KL; Antoni FA
    J Neurochem; 2002 May; 81(3):422-33. PubMed ID: 12065651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels.
    Rochais F; Vandecasteele G; Lefebvre F; Lugnier C; Lum H; Mazet JL; Cooper DM; Fischmeister R
    J Biol Chem; 2004 Dec; 279(50):52095-105. PubMed ID: 15466415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.
    Afzal F; Andressen KW; Mørk HK; Aronsen JM; Sjaastad I; Dahl CP; Skomedal T; Levy FO; Osnes JB; Qvigstad E
    Br J Pharmacol; 2008 Dec; 155(7):1005-14. PubMed ID: 18846035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases.
    Baillie GS; MacKenzie SJ; McPhee I; Houslay MD
    Br J Pharmacol; 2000 Oct; 131(4):811-9. PubMed ID: 11030732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of murine cardiac function by phosphodiesterases type 3 and 4.
    Beca S; Aschars-Sobbi R; Panama BK; Backx PH
    Curr Opin Pharmacol; 2011 Dec; 11(6):714-9. PubMed ID: 22047792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β2-adrenergic receptor-coupled phosphoinositide 3-kinase constrains cAMP-dependent increases in cardiac inotropy through phosphodiesterase 4 activation.
    Gregg CJ; Steppan J; Gonzalez DR; Champion HC; Phan AC; Nyhan D; Shoukas AA; Hare JM; Barouch LA; Berkowitz DE
    Anesth Analg; 2010 Oct; 111(4):870-7. PubMed ID: 20705779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of cyclic nucleotide phosphodiesterases in the cAMP compartmentation in cardiac cells].
    Mika D; Leroy J; Vandecasteele G; Fischmeister R
    Biol Aujourdhui; 2012; 206(1):11-24. PubMed ID: 22463992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure.
    Ding B; Abe JI; Wei H; Huang Q; Walsh RA; Molina CA; Zhao A; Sadoshima J; Blaxall BC; Berk BC; Yan C
    Circulation; 2005 May; 111(19):2469-2476. PubMed ID: 15867171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.
    Nishi A; Kuroiwa M; Miller DB; O'Callaghan JP; Bateup HS; Shuto T; Sotogaku N; Fukuda T; Heintz N; Greengard P; Snyder GL
    J Neurosci; 2008 Oct; 28(42):10460-71. PubMed ID: 18923023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of signaling through GPCR-cAMP-PKA pathways by PDE4 depends on stimulus intensity: Possible implications for the pathogenesis of acrodysostosis without hormone resistance.
    Motte E; Le Stunff C; Briet C; Dumaz N; Silve C
    Mol Cell Endocrinol; 2017 Feb; 442():1-11. PubMed ID: 27908835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.